RENOVORX, INC. (RNXT) Current Ratio
- Current ratio · latest quarter: Value 5.74×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 5.74× | Current assets / current liabilities. $10.81M ÷ $1.88M ≈ 5.74× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 10.81M USD | Assets, Current |
| Current obligations | 1.88M USD | Liabilities, Current |
| Cash and equivalents | 9.48M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 480.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 383.00K USD | Inventory, Net |
| Payables | 866.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.81M | $1.88M | $9.48M | (m) | $480.00K | $383.00K | $866.00K | (m) | 5.74× |
| 2026-03-31 | $13.72M | $1.92M | $12.36M | (m) | $280.00K | $379.00K | $1.12M | (m) | 7.15× |
| 2025-12-31 | $7.89M | $1.96M | $7.02M | (m) | $139.00K | $189.00K | $799.00K | (m) | 4.02× |
| 2025-09-30 | $10.98M | $1.88M | $10.04M | (m) | $169.00K | $272.00K | $869.00K | (m) | 5.83× |
| 2025-06-30 | $13.39M | $1.56M | $12.31M | (m) | $363.00K | (m) | $671.00K | (m) | 8.61× |
| 2025-03-31 | $15.74M | $1.74M | $14.58M | (m) | $242.00K | (m) | $967.00K | (m) | 9.07× |
| 2024-12-31 | $7.83M | $1.91M | $7.15M | (m) | $43.00K | $0.00 | $586.00K | (m) | 4.10× |
| 2023-12-31 | $1.47M | $1.18M | $1.17M | (m) | (m) | (m) | $561.00K | (m) | 1.25× |
| 2021-09-30 | $18.16M | $625.00K | $17.73M | (m) | (m) | (m) | $133.00K | (m) | 29.06× |
| 2020-12-31 | $1.91M | $4.10M | $1.79M | (m) | (m) | (m) | $162.00K | (m) | 0.47× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |